Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders
    3.
    发明授权
    Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders 有权
    黄酮二酮衍生物用于治疗色素沉着和皮肤老化障碍

    公开(公告)号:US08906416B2

    公开(公告)日:2014-12-09

    申请号:US13808456

    申请日:2011-07-08

    摘要: The invention relates to compound of generic formula (I) in which: R1 and R2 represent: OH, a hydrogen atom, a C1-C6 alkyl radical a C1-C6 alkoxy radical, a halogen, or OCOR3; R3 represents: a C1-C24 alkyl radical a C12-C24 alkenyl radical comprising at least one unsaturation; R4 represents: COR5, a glucide substituted or not by one or more acetyl radical(s); R5 represents: a C10-C24 alkyl radical or a C12-C24 alkenyl radical comprising at least one unsaturation; R6 and R7 represent:—simultaneously a hydrogen atom or a methyl radical, or—when R6 represents a hydrogen atom, R7 represents a C1-C6 alkyl radical or a phenyl substituted or not by one or more C1-C3 alkoxy radical(s) or one or more halogen(s) or—R6 and R7 are bonded together and form a C3-C6 cycloalkyl, and pharmaceutically or cosmetically acceptable salts.

    摘要翻译: 本发明涉及通式(I)的化合物,其中:R 1和R 2表示:OH,氢原子,C 1 -C 6烷基,C 1 -C 6烷氧基,卤素或OCOR 3; R3表示:C1-C24烷基,包含至少一个不饱和键的C 12 -C 24烯基; R4表示:COR5,被一个或多个乙酰基取代或不被一个或多个乙酰基取代的糖; R5表示:包含至少一个不饱和键的C 10 -C 24烷基或C 12 -C 24烯基; R6和R7表示: - 同时为氢原子或甲基,或 - 当R6表示氢原子时,R7表示C1-C6烷基或被一个或多个C1-C3烷氧基取代或未取代的苯基, 或一个或多个卤素或-R 6和R 7键合在一起并形成C 3 -C 6环烷基,以及药学上或化妆品上可接受的盐。

    XANTHENEDIONE DERIVATIVES FOR THE TREATMENT OF PIGMENTATION AND SKIN AGEING DISORDERS
    8.
    发明申请
    XANTHENEDIONE DERIVATIVES FOR THE TREATMENT OF PIGMENTATION AND SKIN AGEING DISORDERS 有权
    用于治疗感染和皮肤老化症状的XENTHENEDIONE衍生物

    公开(公告)号:US20130108568A1

    公开(公告)日:2013-05-02

    申请号:US13808456

    申请日:2011-07-08

    摘要: The invention relates to compound of generic formula (I) in which: R1 and R2 represent: OH, a hydrogen atom, a C1-C6 alkyl radical a C1-C6 alkoxy radical, a halogen, or OCOR3; R3 represents: a C1-C24 alkyl radical a C12-C24 alkenyl radical comprising at least one unsaturation; R4 represents: COR5, a glucide substituted or not by one or more acetyl radical(s); R5 represents: a C10-C24 alkyl radical or a C12-C24 alkenyl radical comprising at least one unsaturation; R6 and R7 represent:—simultaneously a hydrogen atom or a methyl radical, or—when R6 represents a hydrogen atom, R7 represents a C1-C6 alkyl radical or a phenyl substituted or not by one or more C1-C3 alkoxy radical(s) or one or more halogen(s) or—R6 and R7 are bonded together and form a C3-C6 cycloalkyl, and pharmaceutically or cosmetically acceptable salts.

    摘要翻译: 本发明涉及通式(I)的化合物,其中:R 1和R 2表示:OH,氢原子,C 1 -C 6烷基,C 1 -C 6烷氧基,卤素或OCOR 3; R3表示:C1-C24烷基,包含至少一个不饱和键的C 12 -C 24烯基; R4表示:COR5,被一个或多个乙酰基取代或不被一个或多个乙酰基取代的糖; R5表示:包含至少一个不饱和键的C 10 -C 24烷基或C 12 -C 24烯基; R6和R7表示: - 同时为氢原子或甲基,或 - 当R6表示氢原子时,R7表示C1-C6烷基或被一个或多个C1-C3烷氧基取代或未取代的苯基, 或一个或多个卤素或-R 6和R 7键合在一起并形成C 3 -C 6环烷基,以及药学上或化妆品上可接受的盐。